Surgery Partners, Inc.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$885M
↑+2.4% +$21Mvs FY2024 (Q4)
Gross Profit
$885M
↑+2.4% +$21Mvs FY2024 (Q4)
Operating Income
$110M
↓-13.3% -$17Mvs FY2024 (Q4)
Net Income
$29M
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $885M | $864M |
| COGS | $0 | $0 |
| Gross Profit | $885M | $864M |
| R&D | $0 | $0 |
| SG&A | $0 | $0 |
| D&A | $60M | $34M |
| Other OpEx | $715M | $703M |
| Operating Income | $110M | $127M |
| Interest Exp. | $68M | $53M |
| Other Non-Op | $0 | $0 |
| Pretax Income | $43M | $74M |
| Tax | $14M | $74M |
| Net Income | $29M | $0 |
QuarterCharts · SEC EDGAR data · SGRY · Comparing FY2025 (Q4) vs FY2024 (Q4)